Comparison of MS outcomes after Switching to Natalizumab versus staying on Interferon-beta or glatiramer

---

Spelman T., Izquierdo G., Lugaresi A., Alroughani R., Duquette P., Boz C., ...More

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, vol.22, pp.600-602, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 22
• City: London
• Country: Canada
• Page Numbers: pp.600-602
• Karadeniz Technical University Affiliated: Yes